New South Wales govt launches Medical Devices Fund

Updated on 4 September 2012

The Medical Devices Fund will support individuals, public and private hospitals, medical research institutes, universities and research organizations to take local innovations to a worldwide market

medical-devices-fund-nsw

The NSW Government has committed $5 million annually for a new Medical Devices seeding fund

Singapore: The New South Wales (NSW) Government in Australia has established a Medical Devices Fund under which it will aid development and commercialization of innovative medical devices in the state.

NSW Minister for Medical Research Ms Jillian Skinner announced the establishment of the new fund and called for applications seeking support for developmental research and commercialization of medical devices in NSW. "The establishment of the Medical Devices Fund was a key election commitment for the NSW Government and reflects our support for medical research in this state," said Ms Skinner.

The NSW Government has committed $5 million annually for a new Medical Devices seeding fund to support the development of medical devices to further better treatment options and patient outcomes. The government has boosted the funds available in its inaugural year, 2012-2013, to make $8 million available. "This fund will foster design and development of medical devices while also promoting their potential uses and benefits. Investment in quality medical research, including the development of medical devices and technology, supports innovative clinical outcomes as well as contemporary methods of care for patients," she said.

The Medical Devices Fund will support individuals, public and private hospitals, medical research institutes, universities, other public sector research organizations and the medical devices industry to take local innovations to a worldwide market.

Preliminary application submission process will close on October 10, 2012.

Previous 1

Leave a Reply

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X